From Clinical Thyroidology® for the Public: Amiodarone-induced thyrotoxicosis (AIT) can be difficult to treat because there are two different types that need different treatments. Since patients who are treated with amiodarone have underlying heart disease, it is important to quickly control thyrotoxicosis in these patients to minimize its impact on heart. This study examined whether the initial treatment received by patients with AIT affects cardiovascular outcomes.. Read More…
We welcome your feedback and suggestions. Let us know what you want to see in this publication.
Feedback & Suggestions
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.